VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 31.36 Million EUR | 5.87% |
| 2022 | 28.72 Million EUR | 85.24% |
| 2021 | 15.5 Million EUR | 67.09% |
| 2020 | 9.28 Million EUR | -0.56% |
| 2019 | 9.33 Million EUR | -0.1% |
| 2018 | 9.34 Million EUR | -12.4% |
| 2017 | 10.66 Million EUR | 36.03% |
| 2016 | 7.84 Million EUR | -1.83% |
| 2015 | 7.98 Million EUR | 24.33% |
| 2014 | 6.42 Million EUR | -2.59% |
| 2013 | 6.59 Million EUR | -24.95% |
| 2012 | 8.78 Million EUR | -10.32% |
| 2011 | 9.79 Million EUR | -2.81% |
| 2010 | 10.08 Million EUR | 1.03% |
| 2009 | 9.97 Million EUR | -17.4% |
| 2008 | 12.07 Million EUR | 7.59% |
| 2007 | 11.22 Million EUR | 309.17% |
| 2006 | -5.36 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.71 Million EUR | 2.85% |
| 2024 Q1 | 7.97 Million EUR | 4.93% |
| 2023 Q3 | 9.02 Million EUR | 17.86% |
| 2023 Q4 | 7.6 Million EUR | -15.82% |
| 2023 Q1 | 7.21 Million EUR | -1.81% |
| 2023 FY | 30.41 Million EUR | 5.87% |
| 2023 Q2 | 7.66 Million EUR | 6.23% |
| 2022 Q2 | 7.5 Million EUR | 10.55% |
| 2022 FY | 28.72 Million EUR | 85.24% |
| 2022 Q3 | 7.09 Million EUR | -5.39% |
| 2022 Q4 | 7.34 Million EUR | 3.47% |
| 2022 Q1 | 6.78 Million EUR | -3.66% |
| 2021 Q2 | 3 Million EUR | 3.98% |
| 2021 Q4 | 7.04 Million EUR | 173.34% |
| 2021 Q3 | 2.57 Million EUR | -14.19% |
| 2021 FY | 15.5 Million EUR | 67.09% |
| 2021 Q1 | 2.88 Million EUR | 8.12% |
| 2020 Q1 | 2.21 Million EUR | -13.01% |
| 2020 Q4 | 2.67 Million EUR | 18.66% |
| 2020 Q2 | 2.14 Million EUR | -3.07% |
| 2020 FY | 9.28 Million EUR | -0.56% |
| 2020 Q3 | 2.25 Million EUR | 4.89% |
| 2019 Q1 | 2.21 Million EUR | 9.41% |
| 2019 FY | 9.33 Million EUR | -0.1% |
| 2019 Q2 | 2.24 Million EUR | 1.49% |
| 2019 Q3 | 2.33 Million EUR | 4.15% |
| 2019 Q4 | 2.54 Million EUR | 8.95% |
| 2018 Q2 | 2.47 Million EUR | 3.43% |
| 2018 Q3 | 2.46 Million EUR | -0.2% |
| 2018 Q4 | 2.02 Million EUR | -18.05% |
| 2018 FY | 9.34 Million EUR | -12.4% |
| 2018 Q1 | 2.38 Million EUR | -10.49% |
| 2017 Q3 | 2.52 Million EUR | -27.15% |
| 2017 Q1 | 2 Million EUR | -12.61% |
| 2017 FY | 10.66 Million EUR | 36.03% |
| 2017 Q4 | 2.66 Million EUR | 5.58% |
| 2017 Q2 | 3.46 Million EUR | 73.28% |
| 2016 FY | 7.84 Million EUR | -1.83% |
| 2016 Q3 | 1.8 Million EUR | -5.65% |
| 2016 Q4 | 2.29 Million EUR | 27.07% |
| 2016 Q2 | 1.91 Million EUR | 4.08% |
| 2016 Q1 | 1.83 Million EUR | -38.66% |
| 2015 Q4 | 2.99 Million EUR | 59.88% |
| 2015 Q3 | 1.87 Million EUR | 9.15% |
| 2015 Q1 | 1.4 Million EUR | -3.96% |
| 2015 FY | 7.98 Million EUR | 24.33% |
| 2015 Q2 | 1.71 Million EUR | 21.98% |
| 2014 Q1 | 1.55 Million EUR | 2.1% |
| 2014 Q2 | 1.64 Million EUR | 5.53% |
| 2014 Q3 | 1.76 Million EUR | 7.62% |
| 2014 Q4 | 1.46 Million EUR | -17.05% |
| 2014 FY | 6.42 Million EUR | -2.59% |
| 2013 Q4 | 1.52 Million EUR | -10.47% |
| 2013 Q3 | 1.7 Million EUR | 9.96% |
| 2013 Q2 | 1.54 Million EUR | -15.33% |
| 2013 Q1 | 1.82 Million EUR | -4.45% |
| 2013 FY | 6.59 Million EUR | -24.95% |
| 2012 Q2 | 2.34 Million EUR | 5.92% |
| 2012 FY | 8.78 Million EUR | -10.32% |
| 2012 Q3 | 2.31 Million EUR | -1.11% |
| 2012 Q4 | 1.91 Million EUR | -17.56% |
| 2012 Q1 | 2.21 Million EUR | 3.03% |
| 2011 Q2 | 2.59 Million EUR | -0.19% |
| 2011 Q3 | 2.45 Million EUR | -5.66% |
| 2011 FY | 9.79 Million EUR | -2.81% |
| 2011 Q4 | 2.14 Million EUR | -12.33% |
| 2011 Q1 | 2.6 Million EUR | 5.77% |
| 2010 Q2 | 2.6 Million EUR | 25.52% |
| 2010 Q1 | 2.07 Million EUR | -24.53% |
| 2010 FY | 10.08 Million EUR | 1.03% |
| 2010 Q4 | 2.46 Million EUR | -16.21% |
| 2010 Q3 | 2.93 Million EUR | 12.62% |
| 2009 Q1 | 2.46 Million EUR | 0.0% |
| 2009 Q3 | 2.46 Million EUR | 7.41% |
| 2009 FY | 9.97 Million EUR | -17.4% |
| 2009 Q4 | 2.75 Million EUR | 11.64% |
| 2009 Q2 | 2.29 Million EUR | -6.9% |
| 2008 Q2 | 3.13 Million EUR | 0.0% |
| 2008 FY | 12.07 Million EUR | 7.59% |
| 2007 FY | 11.22 Million EUR | 309.17% |
| 2006 FY | -5.36 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 3.55 Billion EUR | 99.118% |
| Fresenius SE & Co. KGaA | 3.91 Billion EUR | 99.199% |
| LIMES Schlosskliniken AG | 11.2 Million EUR | -179.894% |
| M1 Kliniken AG | 16.77 Million EUR | -86.985% |
| Maternus-Kliniken Aktiengesellschaft | 17.48 Million EUR | -79.407% |
| MEDICLIN Aktiengesellschaft | 70.03 Million EUR | 55.216% |
| RHÖN-KLINIKUM Aktiengesellschaft | 162.47 Million EUR | 80.696% |